Rhabdomyosarcoma other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(8 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Rhabdomyosarcoma}}
{{Rhabdomyosarcoma}}
{{CMG}};{{AE}} {{PSK}}
{{CMG}};{{AE}} {{S.M}}
==Overview==
==Overview==
No additional tests are recommended for the diagnosis of rhabdomyosarcoma.
[[Biopsy]] considered as the most commonly [[diagnostic]] study in [[rhabdomyosarcoma]] and it can be done by open [[surgery]], core-needle [[biopsy]], and fine-needle [[biopsy]]. [[Lumbar puncture]] is an another [[diagnostic]] study in parameningeal [[rhabdomyosarcoma]] and [[meningeal]] involvement cases. [[Bone marrow aspiration]] and [[biopsy]] are usually performed evaluation of [[bone marrow]] involvement due to [[metastases]]. Regional and distant [[lymph nodes]] need to be assessed clinically and radiologically and [[lymph nodes]] that are greater than 1 cm are considered as suspicious ones
==Other Diagnostic Tests==
==Other Diagnostic Tests==
No additional tests are recommended for the diagnosis of rhabdomyosarcoma.
 
===Biopsy===
* [[Tissue]] [[biopsy]] considered as most commonly [[diagnostic]] study in [[rhabdomyosarcoma]].<ref name="pmid19418540">{{cite journal| author=Chowdhury T, Barnacle A, Haque S, Sebire N, Gibson S, Anderson J et al.| title=Ultrasound-guided core needle biopsy for the diagnosis of rhabdomyosarcoma in childhood. | journal=Pediatr Blood Cancer | year= 2009 | volume= 53 | issue= 3 | pages= 356-60 | pmid=19418540 | doi=10.1002/pbc.22059 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19418540  }} </ref>
* There are several ways of taking [[biopsies]] which depends on following criteria:<ref name="pmid24599626">{{cite journal| author=Nunez AL, Elgin JN, Fatima H| title=Fine-needle aspiration biopsy of alveolar rhabdomyosarcoma of Stensen's duct: a case report and review of the literature. | journal=Diagn Cytopathol | year= 2014 | volume= 42 | issue= 12 | pages= 1069-74 | pmid=24599626 | doi=10.1002/dc.23084 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24599626  }} </ref><ref name=":0">Kaseb H, Babiker HM. Cancer, Rhabdomyosarcoma. [Updated 2018 Oct 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507721/</ref>
** Patients's [[age]]
** Primary site of [[tumor]]
* Open [[surgical]] [[biopsy]] is considered as a recommended method to obtaining [[tissues]] and proper [[diagnosis]].<ref>PDQ Pediatric Treatment Editorial Board. Childhood Rhabdomyosarcoma Treatment (PDQ®): Patient Version. 2019 Jan 30. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK65839/</ref>
* Needle [[biopsies]] are considered as less [[invasive]] way of taking [[biopsies]].
** Core-needle [[biopsy]]
** Fine- needle [[biopsy]]
=== Lumbar puncture===
* [[Lumbar puncture]] is considered as unnecessary procedure in [[rhabdomyosarcoma]] [[diagnosis]].<ref name="pmid23940218">{{cite journal| author=Weiss AR, Lyden ER, Anderson JR, Hawkins DS, Spunt SL, Walterhouse DO et al.| title=Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee. | journal=J Clin Oncol | year= 2013 | volume= 31 | issue= 26 | pages= 3226-32 | pmid=23940218 | doi=10.1200/JCO.2012.44.6476 | pmc=3757291 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23940218  }} </ref>
* [[Lumbar puncture]] is usually done in parameningeal [[rhabdomyosarcoma]].
* Also may be considered as a [[Diagnostic study of choice|diagnostic study]] in rhabdomyosarcoma with [[meningeal]] involvement.
=== Bone marrow aspiration and biopsy===
* [[Bone marrow aspiration]] is usually performed for evaluation of [[bone marrow]] involvement due to [[metastases]].<ref name=":0" /><ref name="pmid23940218" />
* The samples are taken from [[pelvic]] [[bones]].
* It is considered as low yield [[diagnostic]] study.
=== Lymph node assessment===
* Regional and distant [[lymph nodes]] need to be assessed clinically and radiologically.<ref name="pmid20542386">{{cite journal| author=La TH, Wolden SL, Rodeberg DA, Hawkins DS, Brown KL, Anderson JR et al.| title=Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group. | journal=Int J Radiat Oncol Biol Phys | year= 2011 | volume= 80 | issue= 4 | pages= 1151-7 | pmid=20542386 | doi=10.1016/j.ijrobp.2010.03.050 | pmc=3116031 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20542386  }} </ref>
* [[Lymph nodes]] that are greater than 1 cm are considered as suspicious ones.
* If [[lymph nodes]] involvement have been seen more than locoregional areas, stage IV of [[rhabdomyosarcoma]] is confirmed.
* In extremity [[tumors]], transit [[lymph nodes]] must be assessed aggressively due to higher [[positive]] [[incidence]].
* [[Sentinel lymph node]] technique and regional nodal [[sampling]] are used for [[surgical]] [[lymph node]] assessment.


==References==
==References==
Line 14: Line 37:


[[Category:Disease]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Orthopedics]]

Latest revision as of 17:28, 8 March 2019

Rhabdomyosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rhabdomyosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rhabdomyosarcoma other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rhabdomyosarcoma other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rhabdomyosarcoma other diagnostic studies

CDC on Rhabdomyosarcoma other diagnostic studies

Rhabdomyosarcoma other diagnostic studies in the news

Blogs on Rhabdomyosarcoma other diagnostic studies

Directions to Hospitals Treating Rhabdomyosarcoma

Risk calculators and risk factors for Rhabdomyosarcoma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Biopsy considered as the most commonly diagnostic study in rhabdomyosarcoma and it can be done by open surgery, core-needle biopsy, and fine-needle biopsy. Lumbar puncture is an another diagnostic study in parameningeal rhabdomyosarcoma and meningeal involvement cases. Bone marrow aspiration and biopsy are usually performed evaluation of bone marrow involvement due to metastases. Regional and distant lymph nodes need to be assessed clinically and radiologically and lymph nodes that are greater than 1 cm are considered as suspicious ones

Other Diagnostic Tests

Biopsy

Lumbar puncture

Bone marrow aspiration and biopsy

Lymph node assessment

References

  1. Chowdhury T, Barnacle A, Haque S, Sebire N, Gibson S, Anderson J; et al. (2009). "Ultrasound-guided core needle biopsy for the diagnosis of rhabdomyosarcoma in childhood". Pediatr Blood Cancer. 53 (3): 356–60. doi:10.1002/pbc.22059. PMID 19418540.
  2. Nunez AL, Elgin JN, Fatima H (2014). "Fine-needle aspiration biopsy of alveolar rhabdomyosarcoma of Stensen's duct: a case report and review of the literature". Diagn Cytopathol. 42 (12): 1069–74. doi:10.1002/dc.23084. PMID 24599626.
  3. 3.0 3.1 Kaseb H, Babiker HM. Cancer, Rhabdomyosarcoma. [Updated 2018 Oct 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507721/
  4. PDQ Pediatric Treatment Editorial Board. Childhood Rhabdomyosarcoma Treatment (PDQ®): Patient Version. 2019 Jan 30. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK65839/
  5. 5.0 5.1 Weiss AR, Lyden ER, Anderson JR, Hawkins DS, Spunt SL, Walterhouse DO; et al. (2013). "Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee". J Clin Oncol. 31 (26): 3226–32. doi:10.1200/JCO.2012.44.6476. PMC 3757291. PMID 23940218.
  6. La TH, Wolden SL, Rodeberg DA, Hawkins DS, Brown KL, Anderson JR; et al. (2011). "Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group". Int J Radiat Oncol Biol Phys. 80 (4): 1151–7. doi:10.1016/j.ijrobp.2010.03.050. PMC 3116031. PMID 20542386.

Template:WH Template:WS